Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 9/20 | 0.45 |
| ▸ | NAMPT | P43490 | 4/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | FNTA | P49354 | 3/20 | 0.42 |
| ▸ | FNTB | P49356 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12509388 | 0.91 | ALDH1A1 (0.42) | ALDH1A1FAAHNAMPT | |
| SCHEMBL12508570 | 0.91 | FAAH (0.46) | ALDH1A1FAAHNAMPTCYP2D6 | |
| SCHEMBL25120372 | 0.91 | NAMPT (0.48) | ALDH1A1FAAHNAMPT | |
| SCHEMBL12509192 | 0.89 | ALDH1A1 (0.52) | ALDH1A1FAAHNAMPTTRPV1CYP2D6 | |
| SCHEMBL12508835 | 0.89 | ALDH1A1 (0.51) | ALDH1A1FAAH | |
| SCHEMBL12509061 | 0.88 | ALDH1A1 (0.43) | ALDH1A1NAMPT | |
| SCHEMBL12509073 | 0.87 | ALDH1A1 (0.51) | ALDH1A1FAAHNAMPTTRPV1 | |
| SCHEMBL2196108 | 0.87 | FAAH (0.57) | FAAHCYP2D6 | |
| SCHEMBL12509410 | 0.87 | ALDH1A1 (0.53) | ALDH1A1FAAHNAMPT | |
| SCHEMBL2192802 | 0.86 | ALDH1A1 (0.43) | ALDH1A1FAAHNAMPTCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110172230-A1 | UREA COMPOUND OR SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172230-A1 | UREA COMPOUND OR SALT THEREOF | FAAH, FAAH2, UTS2R | ALDH1A1 259/4885FAAH 1/4885NAMPT 1212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.